Browse drugs

…low. No deaths were reported.Conclusions These findings suggest fremanezumab provides a well-tolerated preventive migraine treatment option …

… versus when symptoms of both migraine and MDD are treated with fremanezumab (alternate scenario). The model included people with migraine a…

…al for cardiovascular or cerebrovascular events associated with rimegepant. Routine pharmacovigilance is ongoing, including a Post Authori…

… were requested across the majority of samples, whereas NFL and S100 were requested infrequently. No p-tau requests were received.28…

…Lamotrigine pharmacokinetics alter during pregnancy often necessitating dos…

…04998812) is a prospective Phase IV, open-label study measuring ocrelizumab placental transfer, infant B-cell levels and detailed maternal …

…Objective To evaluate the long-term safety and efficacy of nipocalimab, an FcRn blocker, in patients with generalized myasthenia gravi…

… varied depending on whether a neurologist was involved or not (steroids 90.7% vs. 81.8%; IVIg 25.6% vs. 9.1%; PLEX 16.3% vs. 9.1%). Alt…

…term consequences and significant risk of longer-term morbidity.Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor, u…

…ous haemorrhage and infarct were common complications in 42.4%. Dabigatran was the most frequently used anticoagulant in 51.1%, whilst war…

…Introduction Daridorexant is a dual orexin receptor antagonist approved for the treatment…

…Procedural sedation and analgesia (PSA) is generally considered safe, yet fatal events remain poorly c…